Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;237(10):3752-3767.
doi: 10.1002/jcp.30846. Epub 2022 Aug 12.

The role of endoplasmic reticulum stress in the regulation of long noncoding RNAs in cancer

Affiliations
Review

The role of endoplasmic reticulum stress in the regulation of long noncoding RNAs in cancer

Nasim Ebrahimi et al. J Cell Physiol. 2022 Oct.

Abstract

Cancer cells must overcome a variety of external and internal stresses to survive and proliferate. These unfavorable conditions include the accumulation of mutations, nutrient deficiency, oxidative stress, and hypoxia. These stresses can cause aggregation of misfolded proteins inside the endoplasmic reticulum. Under these conditions, the cell undergoes endoplasmic reticulum stress (ER-stress), and consequently initiates the unfolded protein response (UPR). Activation of the UPR triggers transcription factors and regulatory factors, including long noncoding RNAs (lncRNAs), which control the gene expression profile to maintain cellular stability and hemostasis. Recent investigations have shown that cancer cells can ensure their survival under adverse conditions by the UPR affecting the expression of lncRNAs. Therefore, understanding the relationship between lncRNA expression and ER stress could open new avenues, and suggest potential therapies to treat various types of cancer.

Keywords: ER stress; cell survival; long noncoding RNAs; signaling pathways; unfolded protein response (UPR).

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Alasiri, G., Jiramongkol, Y., Zona, S., Fan, L. Y.-N., Mahmud, Z., Gong, G., Lee, H. J., & Lam, E. W.-F. (2019). Regulation of PERK expression by FOXO3: A vulnerability of drug-resistant cancer cells. Oncogene, 38(36), 6382-6398.
    1. Araki, K., & Nagata, K. (2011). Protein folding and quality control in the ER. Cold Spring Harbor Perspectives in Biology, 3(11), a007526.
    1. Axten, J. M., Medina, J. S. R., Feng, Y., Shu, A., Romeril, S. P., Grant, S. W., Li, W. H. H., Heerding, D. A., Minthorn, E., & Mencken, T. (2012). Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl) phenyl] acetyl}-2,3-dihydro-1 H-indol-5-yl)-7H-pyrrolo [2, 3-d] pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). Journal of Medicinal Chemistry, 55(16), 7193-7207.
    1. Axten, J. M., Romeril, S. P., Shu, A., Ralph, J., Medina, J. R., Feng, Y., Li, W. H. H., Grant, S. W., Heerding, D. A., & Minthorn, E. (2013). Discovery of GSK2656157: An optimized PERK inhibitor selected for preclinical development. ACS Medicinal Chemistry Letters, 4(10), 964-968.
    1. Bagratuni, T., Wu, P., Gonzalez de Castro, D., Davenport, E. L., Dickens, N. J., Walker, B. A., Boyd, K., Johnson, D. C., Gregory, W., & Morgan, G. J. (2010). XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments. Blood, 116(2), 250-253.

Publication types

MeSH terms

LinkOut - more resources